Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up
Titel:
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up
Auteur:
Colombat, P. Brousse, N. Salles, G. Morschhauser, F. Brice, P. Soubeyran, P. Delwail, V. Deconinck, E. Haioun, C. Foussard, C. Sebban, C. Tilly, H. Thieblemont, C. Bergougnoux, L. Lazreg, F. Solal-Celigny, P.